-+ 0.00%
-+ 0.00%
-+ 0.00%

UBS Maintains Buy on Edwards Lifesciences, Raises Price Target to $118

Benzinga·11/06/2026 00:31:42
Diffusion vocale
UBS analyst Patrick Wood maintains Edwards Lifesciences (NYSE:EW) with a Buy and raises the price target from $110 to $118.